Bioinformatics &

Digital Health

Bioinformatics and Digital Health encompass many different fields of application. Continued advancements in bioinformatics are driving forward key developments in precision medicine, placing the patient at the heart of decisions.

We work with innovators in sequencing, genomics, proteomics, metabolomics and cell biology, as well as biosensors and artificial intelligence. We understand the challenges in this area, and can advise you on how to adapt your IP strategy to deal with these.

Our core bioinformatics team includes attorneys whose practice has a strong focus in this field, with backgrounds in bioinformatics/computational biology, biochemistry, electronics, physics and engineering. They form part of a wider multi-disciplinary team that is over 20-strong and made up of scientists and engineers who have deep knowledge and understanding of the variety of technologies and fields that bioinformatics touches.

We have our finger on the pulse of developments in EPO practice in relation to bioinformatics inventions. We have an impressive record of getting seemingly difficult cases through to grant. 

Digital Health innovations can give rise to a number of valuable assets from data to code, designs of user interfaces, new methods and know-how, each of which can be associated with multiple individual IP rights, both registered and unregistered. Our highly skilled legal team works seamlessly alongside our patent experts to help our clients build a strong bundle of IP rights, including copyrights, trade secrets, database rights, designs and patents. Our integrated team approach means that we can be with you all the way and across the whole spectrum of your IP needs, ensuring efficient, joined-up and commercially relevant advice.

Find out more on our Bioinformatics spotlight page.

Patent_Landscape_in_Bioinformatics_and_Digital_Health_Special_Report_2021-2-Compressed

Special Report

Patent Landscape in Bioinformatics and Digital Health: a data-driven analysis

The words "digital health", "data driven" and "AI" have been on everyone's lips and in many headlines in the healthcare and life sciences sectors over the last couple of years. However, navigating this rapidly changing landscape can be challenging for those in charge of managing the IP associated with the innovations underpinning these changes.  

In this Special Report, we set out to collect data on the patent landscape in the fields of bioinformatics and digital health, to see whether the growth we and our clients see in the field is reflected in the data and whether insights can be gained from the data that will assist in designing better, more informed IP strategies.

Read our blogs

Our clients are at the heart of our Trade Mark business

Our clients are at the heart of our Trade Mark business

We are delighted to release our latest brochure 'Our clients are at the heart of our Trade Mark business'.

UPC Weekly - Battling the Biosimilars: opt-outs, preliminary injunctions & protective letters

UPC Weekly - Battling the Biosimilars: opt-outs, preliminary injunctions & protective letters

2024 Week 17 This week we delve into the details of the first two UPC disputes involving biosimilars. Alexion Pharmaceuticals have launched UPC proceedings against Amgen and Samsung, while Novartis ...

Cleantech Commercialisation Report: Highlights and Trends

Cleantech Commercialisation Report: Highlights and Trends

Today (26 April 2024) the European Patent Office (EPO) and the European Investment Bank (EIB) published an in-depth (and very lengthy) report on financing and commercialisation of cleantech. [For ...

Medical devices: Insights through IP - new report 2024

Medical devices: Insights through IP - new report 2024

We are delighted to release our latest report Medical devices: Insights through IP which looks at the recent IP trends in the medical devices sector.

UPC Weekly - Language of proceedings at the UPC

UPC Weekly - Language of proceedings at the UPC

2024 Week 16 This week we focus on the language of proceedings at the UPC, considering when the defendant can successfully request a change of the language of proceedings, and an overview of the ...

UPC Weekly - Time-dependent transparency of UPC proceedings?

UPC Weekly - Time-dependent transparency of UPC proceedings?

2024 Week 15 The week saw the Court of Appeal issue its decision on public access to court file documents in the Ocado v. Autostore case. We set out the background to the issues in a previous blog. A ...

Forward Magazines Overlapping 6-compressed

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.